Previous 10 | Next 10 |
2024-02-17 03:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $11.595 on volume of 119,263,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.8% to $4.3323 on volume of 111,414,526 shares SoundHound AI Inc. (SOUN) rose 0.0% to $3.7601 on volu...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.3% to $4.3 on volume of 124,140,302 shares Treasure Global Inc. (TGL) rose 60.4% to $0.1588 on volume of 122,843,335 shares PROSHARES TRUST (SQQQ) fell 3.3% to $11.41 on volume...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 5.9% to $4.3207 on volume of 110,964,333 shares PROSHARES TRUST (SQQQ) fell 2.3% to $11.534 on volume of 98,370,244 shares Lyft Inc. (LYFT) rose 34.3% to $16.29 on volume of 91,0...
2024-02-14 10:33:07 ET Read the full article on Seeking Alpha For further details see: DOJ issues subpoena for info on Biogen's foreign operations
2024-02-14 09:50:29 ET More on Biogen Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Biogen Inc. (BIIB) Q4 2023 Earnings Call Transcript Biogen Inc. 2023 Q4 - Results - Earnings Call Presentation Biogen slips as outlook disappo...
2024-02-14 02:55:38 ET Summary Q4 earnings underwhelmed, with misses on EPS and revenue; Leqembi and Zurzuvae's performances were particularly disappointing. Biogen's significant investments in Alzheimer's treatments, especially Leqembi, have yet to yield substantial returns. ...
2024-02-13 14:45:17 ET Image source: The Motley Fool. Biogen (NASDAQ: BIIB) Q4 2023 Earnings Call Feb 13, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Biogen (BIIB) Q4 2023 Earnings Call Transcript
2024-02-13 13:13:00 ET Summary The January headline CPI rose 0.3%; Core CPI up 0.4%. Coca-Cola reports strong Q4 results, Shopify just narrowly tops consensus. Citi says the benchmark index will close out 2024 at 5,100. Listen below or on the go on Apple Podcasts ...
2024-02-13 12:25:05 ET Biogen Inc. (BIIB) Q4 2023 Earnings Conference Call February 13, 2024 8:00 AM ET Company Participants Chuck Triano - Head of Investor Relations Chris Viehbacher - President and Chief Executive Officer Priya Singhal - Head of Development ...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases ...
TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today tha...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...